OBJECTIVE: To evaluate the effects of 24-week exergame intervention in the physical fitness of women with fibromyalgia in both single- and dual-task conditions. DESIGN: Single-blinded, randomized controlled trial. SETTING:University facilities. PARTICIPANTS: Fifty-five women with fibromyalgia, recruited from the local fibromyalgia association, were randomly assigned to one of the two groups: exercise group and control group. INTERVENTION: The exercise group completed 24 weeks of supervised and group-based exergame protocol, divided into two sessions of 60 minutes. The intervention was focused on mobility, postural control, upper and lower limbs coordination, aerobic fitness, and strength. MAIN OUTCOME MEASURES: The strength of the upper limbs was measured using the arm curl test. The mobility skill was assessed through the timed-up and go test, and the flexibility of both upper and lower limbs was measured using the back scratch and the sit and reach tests, respectively. RESULTS:Fifty participants completed the study. In the single-task condition, exergame intervention led to significantly higher effects in the arm curl test (P = 0.008), sit and reach test (P = 0.033), and timed-up and go test (P = 0.021). Moreover, under dual-task condition, exergames led to significant effects in all the physical fitness tests (arm curl test, timed-up and go test, back scratch test, and sit and reach test) compared to the control group. CONCLUSIONS: Exergame is an effective tool to improve the physical fitness in women with fibromyalgia under single or dual-task conditions.
RCT Entities:
OBJECTIVE: To evaluate the effects of 24-week exergame intervention in the physical fitness of women with fibromyalgia in both single- and dual-task conditions. DESIGN: Single-blinded, randomized controlled trial. SETTING: University facilities. PARTICIPANTS: Fifty-five women with fibromyalgia, recruited from the local fibromyalgia association, were randomly assigned to one of the two groups: exercise group and control group. INTERVENTION: The exercise group completed 24 weeks of supervised and group-based exergame protocol, divided into two sessions of 60 minutes. The intervention was focused on mobility, postural control, upper and lower limbs coordination, aerobic fitness, and strength. MAIN OUTCOME MEASURES: The strength of the upper limbs was measured using the arm curl test. The mobility skill was assessed through the timed-up and go test, and the flexibility of both upper and lower limbs was measured using the back scratch and the sit and reach tests, respectively. RESULTS: Fifty participants completed the study. In the single-task condition, exergame intervention led to significantly higher effects in the arm curl test (P = 0.008), sit and reach test (P = 0.033), and timed-up and go test (P = 0.021). Moreover, under dual-task condition, exergames led to significant effects in all the physical fitness tests (arm curl test, timed-up and go test, back scratch test, and sit and reach test) compared to the control group. CONCLUSIONS: Exergame is an effective tool to improve the physical fitness in women with fibromyalgia under single or dual-task conditions.
Authors: Santos Villafaina; Yolanda Borrega-Mouquinho; Juan Pedro Fuentes-García; Daniel Collado-Mateo; Narcis Gusi Journal: Int J Environ Res Public Health Date: 2019-12-24 Impact factor: 3.390
Authors: María Del-Moral-García; Esteban Obrero-Gaitán; Daniel Rodríguez-Almagro; Manuel Rodríguez-Huguet; María Catalina Osuna-Pérez; Rafael Lomas-Vega Journal: J Clin Med Date: 2020-11-22 Impact factor: 4.241
Authors: Jesús Sánchez-Gómez; Santos Villafaina; Francisco Javier Domínguez-Muñoz; Juan Luis Leon-Llamas; Alvaro Murillo-Garcia; Narcis Gusi Journal: Biology (Basel) Date: 2022-06-21
Authors: Juan Manuel Franco-García; Jorge Carlos-Vivas; Damián Pereira-Payo; José Carmelo Adsuar; María Mendoza-Muñoz; Manuel Granado-Sánchez; Raquel Pastor-Cisneros; Laura Muñoz-Bermejo; Sabina Barrios-Fernández; Hadi Nobari; Narcis Gusi; Jorge Pérez-Gómez Journal: Int J Environ Res Public Health Date: 2022-03-06 Impact factor: 3.390